Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer

被引:134
|
作者
Rodina, Anna
Vilenchik, Maria
Moulick, Kamalika
Aguirre, Julia
Kim, Joungnam
Chiang, Anne
Litz, Julie
Clement, Cristina C.
Kang, Yanlong
She, Yuhong
Wu, Nian
Felts, Sara
Wipf, Peter
Massague, Joan
Jiang, Xuejun
Brodsky, Jeffrey L.
Krystal, Geoffrey W.
Chiosis, Gabriela
机构
[1] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23249 USA
[4] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[5] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA
[6] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[7] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA
关键词
D O I
10.1038/nchembio.2007.10
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heat shock protein 90 (Hsp90) has a critical role in malignant transformation. Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood. By using selective compounds, we have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90. Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled. These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.
引用
收藏
页码:498 / 507
页数:10
相关论文
共 50 条
  • [31] Cleavage of HSP90β induced by histone deacetylase inhibitor and proteasome inhibitor modulates cell growth and apoptosis
    Park, Sangkyu
    Jeon, Jae-Hyung
    Park, Jeong-A
    Choi, Jun-Kyu
    Lee, Younghee
    CELL STRESS & CHAPERONES, 2021, 26 (01): : 129 - 139
  • [32] Acquired resistance to HSP90 inhibitor and cancer progression
    Chai, R. C. C.
    Vieusseux, J. L.
    Nguyen, C. H.
    Lang, B. J.
    Kouspou, M. M.
    Price, J. T.
    EJC SUPPLEMENTS, 2010, 8 (07): : 99 - 99
  • [33] Therapeutical potential of radiolabeled HSP90 inhibitor on lung cancers
    Sun, J.
    Lu, L.
    Wu, Q.
    Yang, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S363 - S364
  • [34] Inhibition of thyroid cancer proliferation in vitro by a novel small molecule HSP90 inhibitor
    Cohen, Mark S.
    Patton, Brianne
    Hirsch, Brian
    Rohr, Melanie
    Herre, William
    Blagg, Brian
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3604S - 3604S
  • [35] Antiproliferative effects and signaling profiles of the novel HSP90 inhibitor NVP-AUY922 in non-small cell lung cancer
    Ueno, Tsuyoshi
    Toyooka, Shinichi
    Tsukuda, Kazunori
    Munenori, Takaoka
    Soh, Junichi
    Maki, Yuho
    Muraoka, Takayuki
    Tanaka, Norimitsu
    Asano, Hiroaki
    Yamane, Masaomi
    Oto, Takahiro
    Kiura, Katsuyuki
    Naomoto, Yoshio
    Miyoshi, Shinichiro
    CANCER RESEARCH, 2011, 71
  • [36] Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer
    Ono, Naomi
    Yamazaki, Toshikazu
    Tsukaguchi, Toshiyuki
    Fujii, Toshihiko
    Sakata, Kiyoaki
    Suda, Atsushi
    Tsukuda, Takuo
    Mio, Toshiyuki
    Ishii, Nobuya
    Kondoh, Osamu
    Aoki, Yuko
    CANCER SCIENCE, 2013, 104 (10) : 1346 - 1352
  • [37] Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
    Seung Yeob Hyun
    Huong Thuy Le
    Cong-Truong Nguyen
    Young-Sik Yong
    Hye-Jin Boo
    Ho Jin Lee
    Ji-Sun Lee
    Hye-Young Min
    Jihyae Ann
    Jie Chen
    Hyun-Ju Park
    Jeewoo Lee
    Ho-Young Lee
    Scientific Reports, 8
  • [39] Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
    Hyun, Seung Yeob
    Le, Huong Thuy
    Cong-Truong Nguyen
    Yong, Young-Sik
    Boo, Hye-Jin
    Lee, Ho Jin
    Lee, Ji-Sun
    Min, Hye-Young
    Ann, Jihyae
    Chen, Jie
    Park, Hyun-Ju
    Lee, Jeewoo
    Lee, Ho-Young
    SCIENTIFIC REPORTS, 2018, 8
  • [40] An HSP90 inhibitor based fluorescent probe for selective tumor targeting
    Zhu, Shulei
    Lu, Yingxin
    Jin, Jiyu
    Yu, Jiahui
    Lu, Wei
    DYES AND PIGMENTS, 2021, 196